ABSTRACT Mycobacterium tuberculosis depends on aerobic respiration for growth and utilizes an aa 3 -type cytochrome c oxidase for terminal electron transfer. Cytochrome c maturation in bacteria requires covalent attachment of heme to apocytochrome c, which occurs outside the cytoplasmic membrane. We demonstrate that in M. tuberculosis the thioredoxin-like protein Rv3673c, which we named CcsX, is required for heme insertion in cytochrome c. Inactivation of CcsX resulted in loss of c-type heme absorbance, impaired growth and virulence of M. tuberculosis, and induced cytochrome bd oxidase. This suggests that the bioenergetically less efficient bd oxidase can compensate for deficient cytochrome c oxidase activity, highlighting the flexibility of the M. tuberculosis respiratory chain. A spontaneous mutation in the active site of vitamin K epoxide reductase (VKOR) suppressed phenotypes of the CcsX mutant and abrogated the activity of the disulfide bond-dependent alkaline phosphatase, which shows that VKOR is the major disulfide bond catalyzing protein in the periplasm of M. tuberculosis.
Xxx-Cys-His motif of apocytochrome c (18) (19) (20) (21) . In this study, we identified the ResA/CcsX homolog in M. tuberculosis, encoded by rv3673c, and investigated the consequences of disrupting cytochrome c biogenesis. We provide evidence that the bioenergetically less efficient cytochrome bd oxidase substitutes for impaired CcO activity and that loss of CcsX can be compensated for by a mutation in the disulfide bond-forming protein vitamin K epoxide reductase (VKOR).
RESULTS AND DISCUSSION
Identification of a membrane-bound, periplasmic thioredoxin. We sought to identify the gene encoding M. tuberculosis's ResA/ CcsX and searched for genes encoding proteins predicted to contain a thioredoxin fold and a single transmembrane helix or to be localized to the membrane, using the Tuberculist database (22) and the transmembrane prediction server, TMHMM version 2.0 (23) . Of the proteins that matched our criteria, Rv0526 and Rv3673c were the most likely candidates, with 24% and 33% sequence identity to B. subtilis ResA, respectively. Rv3673c is predicted to contain a single transmembrane helix, and Rv0526 is predicted to be a secreted lipoprotein. We focused on Rv3673c because of its membrane-anchoring transmembrane helix and sequence similarity to ResA even though rv0526 is located in the genomic region that contains the other predicted components of the CCM system. Based on the results of the work presented here, Rv3673 was named CcsX.
To experimentally confirm that the catalytic domain of CcsX is located in the periplasm, we created fusions with alkaline phosphatase (PhoA) at residues leucine 41, serine 47, and proline 65 and expressed them in Mycobacterium smegmatis (see Fig. S2 in the supplemental material). PhoA is active only when located in the oxidizing extracytoplasmic environment and has been used to determine the topology of membrane proteins (24) , including those in mycobacteria (17, 25) . All CcsX-PhoA fusions demonstrated alkaline phosphatase activity (see Fig. S2B in the supplemental material). A plasmid containing PhoA lacking a signal sequence served as a negative control, and a plasmid expressing PhoA fused to the signal sequence of the secreted antigen 85B served as our positive control (25) . Immunoblot analysis of M. tuberculosis expressing Flag-tagged CcsX confirmed its association with the cell membrane/wall fraction (see Fig. S2C ). Taken together, these data suggest that CcsX is a membrane-associated protein with an extracellular thioredoxin domain.
CcsX is required for heme insertion in cytochrome c, and cytochrome bd oxidase can compensate for loss of CcsX. We created an M. tuberculosis mutant strain, the ⌬CcsX mutant, in the background of H37Rv, in which the entire ccsX gene was replaced with a hygromycin cassette. Deletion of ccsX was confirmed by Southern blotting (see Fig. S3 in the supplemental material). To determine the impact of loss of CcsX on CCM, we stained for proteins with covalently bound heme in membrane fractions of M. tuberculosis H37Rv wild type (WT), the ⌬CcsX mutant, and the CcsX-comp complemented mutant. Heme staining of WT membranes revealed five bands at Ͼ150 kDa,~80 kDa,~60 kDa, 25 kDa, and~15 kDa (Fig. 1A) , and we attempted to identify the proteins containing covalently bound heme. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) revealed multiple proteins in each band, at least one of which had a predicted heme-binding motif. Using the LC-MS/MS data, hemebinding motif predictions, and molecular masses, we assigned a heme-bound protein to each band. The band at~80 kDa corresponds to the catalase-peroxidase KatG (26) ; the band at~60 kDa corresponds to SirA, a sulfite reductase with a covalently bound siroheme moiety (27) ; and the band at~25 kDa stems from QcrC, the cytochrome c subunit of the bc 1 cytochrome c reductase complex (8) . Attempts to identify the~15-kDa protein were unsuccessful, and the 150-kDa band appeared to be an aggregate containing more than one of the heme-containing proteins found in the lower-molecular-mass bands. Heme staining of membranes from the ⌬CcsX mutant did not reveal bands for SirA or the~15-kDa protein, and the band corresponding to QcrC was drastically reduced in intensity (Fig. 1A) . This strongly suggested that CcsX is important for cytochrome c assembly. Heme binding to KatG was unaffected by the lack of CcsX, which is not surprising, because KatG is cytosolic and should thus not depend on the extracytoplasmic thioredoxin CcsX for heme attachment. More surprising was the heme deficiency in SirA, formerly known as NirA, a sulfite reductase with covalently bound siroheme (27, 28) . SirA is a predicted cytosolic protein and thus unlikely to rely on the extracytoplasmic CcsX for heme insertion. Siroheme can, however, be hijacked and processed into heme in some bacteria and archaea (29) . The defective heme incorporation into QcrC may have resulted in excessive heme export and depletion of intracellular heme stores, which in turn caused conversion of siroheme to heme, thereby depleting siroheme in SirA. Alternatively, SirA might be an extracytoplasmic protein and directly rely on CcsX for siroheme acquisition, as proteomics identified SirA in the membrane/lipid fractions of M. tuberculosis (30, 31) .
To confirm the loss of c-type heme incorporation into QcrC, reduced minus oxidized difference spectroscopy was used to analyze the cytochrome content of the aerobically grown WT and ⌬CcsX strains. In WT membranes, major absorbance peaks were observed at 552, 563, and 600 nm, characteristic of c-, b-, and a-type cytochromes, respectively (9, 32) (Fig. 1B) . In membranes from the ⌬CcsX mutant, the major peak at 552 nm was no longer visible, indicating a lack of c-type heme. The peak at 563 nm was unchanged; however, a prominent peak was visible at 631 nm, which we did not observe in WT membranes. This peak is characteristic of a d-type heme and has been demonstrated to indicate the presence of the bd oxidase in M. smegmatis following exposure to microaerobic conditions (O 2 Ͻ 1%) but was undetectable when the bacteria were grown aerobically (9) . The bd terminal oxidase is also induced in M. smegmatis lacking the cytochrome bc 1 oxidase (12) and in M. tuberculosis treated with the cytochrome c-specific inhibitors cyanide and azide or agents affecting CCM, such as ZnSO 4 and dithiothreitol (DTT) (33) . Consistent with the hypothesis that bd oxidase is upregulated in the ⌬CcsX mutant to compensate for the perturbation in CCM, mRNA levels of genes of the bd oxidase encoding the cyd operon (cydABDC) were 2-to 3-fold higher in the mutant than in the WT, while expression levels of qcrC and ctaD were unchanged in the ⌬CcsX mutant (Fig. 1C) . Furthermore, the ⌬CcsX mutant was hypersusceptible to cyanide and to the proton-translocating F o F 1 -ATP synthase inhibitor N,N=-dicyclohexylcarbodiimide (DCCD), suggesting impaired cytochrome c oxidase activity and reduced respiratory energy generation (Fig. 1D) . In contrast, the minimal inhibitory concentration of thioridazine (TRZ), a phenothiazine derivative thought to inhibit the type II NADH dehydrogenase (11, 33, 34) , was not different from that of the WT and the ⌬CcsX-comp mutant, suggesting that type II NADH dehydrogenase activity is not decreased in the mutant.
Together, these data demonstrate that (i) CcsX is important for CCM in M. tuberculosis, (ii) Rv0526 is not functionally redundant with CcsX, and (iii) deletion of CcsX is accompanied by increased expression of bd oxidase, suggesting that defective CCM resulted in reduced electron flow through the bc 1 -aa 3 oxidase, which can at least partially be compensated for by increased bd oxidase activity.
Deficient CCM is associated with increased resistance to H 2 O 2 . Consistent with transposon mutagenesis studies, which predicted ccsX to be required for optimal growth (35, 36) , the ⌬CcsX mutant grew slower than the WT on agar plates and in liquid medium ( Fig. 2A and B) . Introducing a copy of ccsX back onto the mutant chromosome complemented these phenotypes. Deletion of ResA/CcsX homologs caused increased resistance to H 2 O 2 treatment in Agrobacterium tumefaciens (37) but hypersusceptibility to H 2 O 2 in Neisseria gonorrhoeae (38) . Consistent with the phenotype in A. tumefaciens, the ⌬CcsX mutant was hyperresistant to H 2 O 2 ( Fig. 2C) , and H 2 O 2 hyperresistance was returned to WT levels in the complemented mutant, confirming that this phenotype was due to the loss of CcsX. This response was specific to H 2 O 2 stress. Exposure to superoxide-generating plumbagin, acidified sodium nitrite resulting in the generation of reactive nitrogen species, and acidification (pH 4.5) did not affect the mutant differently than the WT (see Fig. S4 in the supplemental material). To explore the mechanism responsible for H 2 O 2 hyperresistance, we measured expression of genes important for antioxidant defense in M. tuberculosis (39) (40) (41) (42) . There was no difference in katG mRNA or protein abundance between the ⌬CcsX mutant and the WT (Fig. 2D and E) , similar to the finding that H 2 O 2 hyperresistance of the TlpA (CcsX homolog) mutant in A. tumefaciens was catalase independent (37) . mRNA levels of the thioredoxin genes, trxB1, thiX, and the thioredoxin reductaseencoding trxB2, were also similar in all strains. In contrast, mRNA levels of alkyl hydroperoxide reductase (AhpC) were 2.5-fold increased in the ⌬CcsX mutant and returned to WT levels in the complemented strain (Fig. 2D) . Consistent with the increased mRNA levels, protein amounts of AhpC and AhpD, a thioredoxin-like adaptor protein (43) , were also increased in the ⌬CcsX mutant (Fig. 2E ). AhpC and AhpD are subunits of M. tuberculosis's peroxidase and peroxynitrite reductase complex and have been implicated in oxidative and nitrosative stress responses (39, 42, 43) . However, deletion of ahpC in M. tuberculosis resulted in hypersusceptibility to cumene hydroperoxide but not H 2 O 2 (44). The increased resistance to H 2 O 2 of the ⌬CcsX mutant may also be a consequence of overexpression of the cytochrome bd oxidase, as E. coli cyd mutants are hypersusceptible to H 2 O 2 stress (45, 46) . The cytochrome bd oxidase retains a high affinity for oxygen (47) , and increased expression would result in efficient scavenging of oxygen radicals produced from the breakdown of H 2 O 2 , leading to increased resistance. Consistent with this is the observation that cytochrome bd oxidase plays a respiratory protective role for nitrogen-fixing enzymes which are sensitive to oxidative damage (48) . It is noteworthy that unlike other terminal cytochrome oxidases, the cytochrome bd oxidase does not generate superoxide radicals during catalytic reduction of oxygen, which serves as a barrier for the formation of excessive endogenous oxidative species (49) .
The role of CcsX in pathogenesis. Gene expression analysis revealed that genes encoding subunits of the cytochrome c oxidase and bd oxidase were differentially expressed at different phases of mouse infection (50) . This suggested that cytochrome c oxidase is most important for M. tuberculosis's ability to replicate during the acute phase, while the less-energy-efficient bd oxidase is preferentially required during transition from acute to chronic infection. The ⌬CcsX mutant reached 100-fold-lower CFU than the WT in mouse lungs at day 21 following low-dose aerosol infections, after which it maintained a constant titer (Fig. 3A) . A similar trend was observed in spleens, to which the ⌬CcsX mutant disseminated more slowly than the WT and never reached the same bacterial load (Fig. 3A, right) . Growth in lungs and spleens was restored to WT levels in the complemented mutant (Fig. 3B) . Thus, perturbed CCM affected replication of M. tuberculosis in vivo but had no impact on persistence during chronic mouse infection. These data suggest that bd oxidase can sufficiently substitute for impaired cytochrome c oxidase activity during the chronic phase of the infection when the bacilli are only slowly or not replicating but are exposed to the host-adaptive immune response. In addition to fulfilling a respiratory role in the electron transport chain, cytochrome bd oxidase may protect tubercle bacilli against reactive oxygen species generated through the adaptive immune response. In contrast, normal replication early in infection depends on intact CCM and cytochrome c oxidase activity.
A VKOR mutation compensates for loss of CcsX. During the course of these experiments, especially after multiple passages, the ⌬CcsX phenotypes became less robust. When plating the mutant on 7H10 agar, we noticed a heterogeneous population of colonies, with some significantly larger than others (see Fig. S5A in the supplemental material). Both small and big colonies lacked the ccsX gene, suggesting that the large colonies represented a suppressor mutant (see Fig. S5B and C in the supplemental material). This putative suppressor strain, the ⌬CcsX-S mutant, also grew significantly faster than the ⌬CcsX mutant in liquid medium (Fig. 4A ) and was more susceptible to H 2 O 2 than the ⌬CcsX mutant (see Fig. S5D ). Whole-genome sequencing revealed a point mutation in rv2968c/vkor, resulting in an amino acid change in vitamin K epoxide reductase (VKOR). M. tuberculosis's VKOR is functionally similar to DsbB in E. coli (51, 52) , which together with DsbA catalyzes disulfide bond formation in the periplasm (53) . The ⌬CcsX-S mutation caused the proline residue at position 140 to be replaced with a serine (Fig. 4B) . This proline lies in the Cys-Xxx-Xxx-Cys thioredoxin active site and is conserved in most thioredoxin family members (54, 55) . TMHMM predicts that this sequence in VKOR is located in the periplasmic space consistent with its function. To determine whether the substitution of proline with serine affected the function of VKOR, we expressed the antigen 85B secretion signal-PhoA fusion protein, whose activity depends on intramolecular disulfide bond formation (56) , in the WT, the ⌬CcsX mutant, and the ⌬CcsX-S mutant and measured alkaline phosphatase activity. PhoA activity was drastically reduced in the ⌬CcsX-S mutant compared to in the other strains, suggesting that the point mutation in VKOR-P140S impaired disulfide bond formation in the periplasm of the ⌬CcsX-S mutant (Fig. 4C) . Finally we complemented the ⌬CcsX-S mutant with intact VKOR to prove that the suppressor phenotype was caused by the mutated VKOR. Expression of the native, intact vkor gene from a tetracycline repressor-controlled promoter in the ⌬CcsX-S mutant resulted in small colonies, while expression of the mutated gene did not affect growth of the ⌬CcsX-S mutant (Fig. 4D) . Even in the absence of the inducer anhydrotetracycline (atc), the ⌬CcsX-S mutant transformed with WT VKOR formed smaller colonies than when transformed with VKOR-P140S, likely because of leaky expression. The addition of atc exacerbated this phenotype. Similarly, growth of the ⌬CcsX-S mutant expressing VKOR in atc-containing liquid medium was significantly reduced compared to that of the untransformed control and mimicked the slow growth of the ⌬CcsX mutant (Fig. 4A) . In contrast, the ⌬CcsX-S mutant transformed with VKOR-P140S replicated like the untransformed ⌬CcsX-S mutant, and the growth of the WT was not affected by either VKOR or VKOR-P140S. Together, these data demonstrate that the point mutation in VKOR caused the suppressor phenotype of the ⌬CcsX-S mutant. Mutations in DsbA and DsbB in Rhodobacter capsulatus (57) and B. subtilis (58) have been demonstrated to compensate for the loss of CcdA and restore (19, 59) . The redox pair DsbA and DsbB forms the disulfide; thus, mutation in either of these proteins or the addition of a reducing agent to the medium abrogates the need for CcdA and ResA/CcsX. Similarly, mutation of VKOR suppressed the defect caused by lack of CcsX. Together, these data not only establish that CcsX is part of M. tuberculosis's CCM system but also support the hypothesis that VKOR is the major disulfide bond catalyzing protein in M. tuberculosis's periplasm.
MATERIALS AND METHODS
Strains, media, and molecular biology techniques. M. tuberculosis (H37Rv) strains were grown in Middlebrook 7H9 or Sauton's medium as described (60) . Cultures were grown aerated in roller bottles rotating at 1 rpm or in stationary tissue culture flasks in small volumes (10 ml) and agitated regularly to ensure aeration. Bacteria were also grown on Middlebrook 7H10 or 7H11 agar plates containing 10% oleic acid-albumindextrose-catalase (OADC) supplement (Becton Dickinson) and 0.5% glycerol. Hygromycin B (50 g/ml), kanamycin (20 g/ml), and streptomycin (20 g/ml) were included when selection was required. The ⌬CcsX mutant was constructed using a suicide plasmid (61) . Gateway cloning technology (Invitrogen) was used for clonings (60) . For complementation, ccsX was cloned downstream of the hsp60 promoter into a plasmid that integrates into the chromosomal attB site and electroporated into the ⌬CcsX mutant. Alkaline phosphatase fusions were created and analyzed as described (25, 62) . RNA isolation and analysis by quantitative real-time PCR was performed as described (60) .
Heme staining and cytochrome spectra. M. tuberculosis lysates were prepared from mid-log-phase cultures, and membranes were isolated as described (63) . Membranes for heme staining were resuspended in ammonium bicarbonate (NH 4 HCO 3 ; Fisher) by sonication until dissolved. A total of 80 g of membrane fraction was separated on a 4 to 15% Tris-HCl gradient gel (Bio-Rad). Heme staining was performed as described (64) . LC-MS/MS analysis of excised bands was performed by the Proteomics Resource Center, Rockefeller University. Membranes for cytochrome spectra were isolated as described above, except TC buffer (10 mM TrisHCl [pH 7.4], 16 mM cholate) was used instead of phosphate-buffered saline (PBS) for lysis and resuspension of the membrane pellet (9) . Reduced minus oxidized cytochrome spectra were recorded on a UV-Vis spectrophotometer (Uvikon XS/XL) at 24°C using a few grains of solid sodium dithionate as reductant and a few drops of 100 or 200 M potassium ferricyanide as oxidant (9) .
Mouse infections. C57BL/6 mice (Jackson Laboratories) were infected using an Inhalation Exposure System (Glas-Col) to deliver~100 to 200 bacilli per mouse. CFU were quantified by plating serial dilutions of lung and spleen homogenates from 4 mice per strain per time point on 7H10 agar. Procedures involving mice were reviewed and approved by the Institutional Animal Care and Use Committee of Weill Cornell Medical College.
Whole genome sequencing and analysis. The ⌬CcsX strain and a large-colony suppressor mutant were sequenced using an Illumina Genome Analyzer IIx. Approximately 5 g of DNA was processed using the standard Illumina sample preparation protocol (Illumina, Inc.), and the samples were sequenced in paired-end mode with a read length of 54 bp. The genome was assembled by mapping reads to the parental H37Rv genome and calling single-nucleotide polymorphisms and insertions/deletions as described (65) . The mean depths of coverage (number of reads covering each site) were 27.9ϫ and 101.2ϫ for the two strains.
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